Menu Search
Equities

CompuGroup Medical SE & Co KgaA

COPX.N:GER

CompuGroup Medical SE & Co KgaA

Actions
Health CareHealth Care Providers
  • Price (EUR)14.05
  • Today's Change-0.07 / -0.50%
  • Shares traded100.57k
  • 1 Year change-62.03%
  • Beta0.7807
Data delayed at least 15 minutes, as of Nov 22 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy4
Outperform4
Hold4
Sell0
Strong Sell0

Share price forecast in EUR

The 11 analysts offering 12 month price targets for CompuGroup Medical SE & Co KgaA have a median target of 20.50, with a high estimate of 70.00 and a low estimate of 16.00. The median estimate represents a 45.91% increase from the last price of 14.05.
High398.2%70.00
Med45.9%20.50
Low13.9%16.00

Dividends in EUR

In 2023, CompuGroup Medical SE & Co KgaA reported a dividend of 1.00 EUR, which represents a 100.00% increase over last year. The 10 analysts covering the company expect dividends of 0.95 EUR for the upcoming fiscal year, a decrease of 5.50%.
Div growth (TTM)100.00%
More ▼

Earnings history & estimates in EUR

On Feb 07, 2024, earnings of 0.56 per share.
The next earnings announcement is expected on Feb 10, 2025.
Average growth rate+4.00%
CompuGroup Medical SE & Co KgaA reported annual 2023 earnings of 2.06 per share on Feb 07, 2024.
Average growth rate-0.21%
More ▼

Revenue history & estimates in EUR

Compugroup Medical SE & Co. KGaA had 3rd quarter 2024 revenues of 283.44m. This missed the 285.00m consensus estimate of the 2 analysts following the company. This was 2.54% below the prior year's 3rd quarter results.
Average growth rate-0.05%
Compugroup Medical SE & Co. KGaA had revenues for the full year 2023 of 1.19bn. This was 5.13% above the prior year's results.
Average growth rate+12.51%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.